Načítá se...
New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities
Venous thromboembolism (VTE) is a major cause of morbidity, mortality, and healthcare expenditure. In the United States, approximately 0.1 % of the population experiences an initial VTE event each year. Anticoagulation therapy is the cornerstone of acute VTE treatment and for prevention of recurrent...
Uloženo v:
| Vydáno v: | Drugs |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4224738/ https://ncbi.nlm.nih.gov/pubmed/25300410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-014-0301-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|